Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Jurnal Ilmu Kefarmasian Indonesia
Delina Hasan
Universitas Pancasila
Biochemistry, Genetics & Molecular Biology Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Analisis Peresepan Obat Formularium Nasional Berdasarkan Kesesuaian Restriksinya di Rumah Sakit Umum Daerah Sawah Besar Tahun 2018 Kuncoro Adi Susanto; Maura Linda Sitanggang; Delina Hasan; Ida Chorida
JURNAL ILMU KEFARMASIAN INDONESIA Vol 19 No 1 (2021): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v19i1.1056

Abstract

Health services provided to the public in the implementation of the National Health Insurance (NHI) includepromotional, preventive, curative and rehabilitative. In supporting the implementation of NHI, it is necessaryto make eff orts to ensure the availability, aff ordability and accessibility of medicines through the application of the National Formulary (Fornas) as a reference in health services in all health facilities. The purpose of this study was to determine the percentage of prescription drugs in accordance with the National Formulary at Sawah Besar Hospital in 2018. The research design descriptive analysis and data collection was carried out retrospectively in the form of prescribing drugs and from the Hospital Management Information System and Patient Medical Record data. This research was conducted with a sample size of around 19.690 recipes and a length of 6 months of research from July 2018 to December 2018. From the results of the study pattern of prescription writing against the suitability of the National Formulary was 71.22%. Compatibility of 75% antihyperlipidemic drugs with atorvastatin as the drug with the most non-conformity of restrictions. The conformity of antihypertension drugs 54.11% with Valsatran as one of the inconsistencies in restriction and insulin drugs, 70.03% the antihyperglycemia drug restriction inconsistencies.
Co-Authors Husnul Hotimah Hasibuan Ida Chorida Kuncoro Adi Susanto MGS Aritonang Sitanggang, Maura Linda